• Single Peptides
    • 5-Amino-1MQ (10 mg Vial) — Evidence profile
    • 5-Amino-1MQ (50 mg Vial) — Evidence profile
    • AOD-9604 (10 mg Vial) — Evidence profile
    • Ara-290 (10 mg Vial) — Evidence profile
    • BPC-157 (10 mg Vial) — Evidence profile
    • Cagrilintide (10 mg Vial) — Evidence profile
    • Cardiogen (20 mg Vial) — Evidence profile
    • Cartalax (20 mg Vial) — Evidence profile
    • CJC 1295 NO DAC (10 mg Vial) — Evidence profile
    • Crystagen (20 mg Vial) — Evidence profile
    • DSIP (10 mg Vial) — Evidence profile
    • Epithalon (10 mg Vial) — Evidence profile
    • Epithalon (50 mg Vial) — Evidence profile
    • GHK-Cu (100 mg Vial) — Evidence profile
    • GHK-Cu (50 mg Vial) — Evidence profile
    • Glutathione (1500 mg Vial) — Evidence profile
    • HCG (5000 IU vial) — Evidence profile
    • IGF-1 LR3 (1 mg Vial) — Evidence profile
    • Ipamorelin (10 mg Vial) — Evidence profile
    • Kisspeptin (10 mg Vial) — Evidence profile
    • KPV (10 mg Vial) — Evidence profile
    • Livagen (20 mg Vial) — Evidence profile
    • LL-37 (5 mg Vial) — Evidence profile
    • LL-37 (10 mg Vial) — Evidence profile
    • Melanotan II (10 mg Vial) — Evidence profile
    • MOTS-C (10 mg Vial) — Evidence profile
    • MOTS-C (40 mg Vial) — Evidence profile
    • NAD (1000 mg vial) — Evidence profile
    • Ovagen (20 mg Vial) — Evidence profile
    • Oxytocin acetate (10 mg vial) — Evidence profile
    • PE-22-28 (10 mg Vial) — Evidence profile
    • Pinealon (10 mg Vial) — Evidence profile
    • Prostamax (20 mg Vial) — Evidence profile
    • PT-141 (10 mg Vial) — Evidence profile
    • Retatrutide (10 mg Vial) — Evidence profile
    • Retatrutide (30 mg Vial) — Evidence profile
    • Retatrutide (50 mg Vial) — Evidence profile
    • Selank (10 mg Vial) — Evidence profile
    • Semaglutide (10 mg Vial) — Evidence profile
    • Semaglutide (30 mg Vial) — Evidence profile
    • Semax (10 mg Vial) — Evidence profile
    • Sermorelin (10 mg Vial) — Evidence profile
    • SLU-PP-332 (5 mg Vial) — Evidence profile
    • SLU-PP-332 (10 mg Vial) — Evidence profile
    • SNAP-8 (10 mg, topical) — Evidence profile
    • SS-31 (10 mg Vial) — Evidence profile
    • SS-31 (50 mg Vial) — Evidence profile
    • TB-500 (10 mg Vial) — Evidence profile
    • Tesamorelin (10 mg Vial) — Evidence profile
    • Testagen (20 mg Vial) — Evidence profile
    • Thymosin Alpha-1 (10 mg Vial) — Evidence profile
    • Tirzepatide (10 mg Vial) — Evidence profile
    • Tirzepatide (50 mg Vial) — Evidence profile
    • Vilon (20 mg Vial) — Evidence profile
  • Peptide Stacks
  • Peptide Blends
    • BPC157 + TB500 (20 mg Blend Vial) — Evidence profile
    • GLOW (70 mg Vial) — Evidence profile
    • KLOW (80 mg Vial) — Evidence profile
  • Calculator
  • Resources
Shopping cart close
PeptideDosing.ca
  • Single Peptides
    • 5-Amino-1MQ (10 mg Vial) — Evidence profile
    • 5-Amino-1MQ (50 mg Vial) — Evidence profile
    • AOD-9604 (10 mg Vial) — Evidence profile
    • Ara-290 (10 mg Vial) — Evidence profile
    • BPC-157 (10 mg Vial) — Evidence profile
    • Cagrilintide (10 mg Vial) — Evidence profile
    • Cardiogen (20 mg Vial) — Evidence profile
    • Cartalax (20 mg Vial) — Evidence profile
    • CJC 1295 NO DAC (10 mg Vial) — Evidence profile
    • Crystagen (20 mg Vial) — Evidence profile
    • DSIP (10 mg Vial) — Evidence profile
    • Epithalon (10 mg Vial) — Evidence profile
    • Epithalon (50 mg Vial) — Evidence profile
    • GHK-Cu (100 mg Vial) — Evidence profile
    • GHK-Cu (50 mg Vial) — Evidence profile
    • Glutathione (1500 mg Vial) — Evidence profile
    • HCG (5000 IU vial) — Evidence profile
    • IGF-1 LR3 (1 mg Vial) — Evidence profile
    • Ipamorelin (10 mg Vial) — Evidence profile
    • Kisspeptin (10 mg Vial) — Evidence profile
    • KPV (10 mg Vial) — Evidence profile
    • Livagen (20 mg Vial) — Evidence profile
    • LL-37 (5 mg Vial) — Evidence profile
    • LL-37 (10 mg Vial) — Evidence profile
    • Melanotan II (10 mg Vial) — Evidence profile
    • MOTS-C (10 mg Vial) — Evidence profile
    • MOTS-C (40 mg Vial) — Evidence profile
    • NAD (1000 mg vial) — Evidence profile
    • Ovagen (20 mg Vial) — Evidence profile
    • Oxytocin acetate (10 mg vial) — Evidence profile
    • PE-22-28 (10 mg Vial) — Evidence profile
    • Pinealon (10 mg Vial) — Evidence profile
    • Prostamax (20 mg Vial) — Evidence profile
    • PT-141 (10 mg Vial) — Evidence profile
    • Retatrutide (10 mg Vial) — Evidence profile
    • Retatrutide (30 mg Vial) — Evidence profile
    • Retatrutide (50 mg Vial) — Evidence profile
    • Selank (10 mg Vial) — Evidence profile
    • Semaglutide (10 mg Vial) — Evidence profile
    • Semaglutide (30 mg Vial) — Evidence profile
    • Semax (10 mg Vial) — Evidence profile
    • Sermorelin (10 mg Vial) — Evidence profile
    • SLU-PP-332 (5 mg Vial) — Evidence profile
    • SLU-PP-332 (10 mg Vial) — Evidence profile
    • SNAP-8 (10 mg, topical) — Evidence profile
    • SS-31 (10 mg Vial) — Evidence profile
    • SS-31 (50 mg Vial) — Evidence profile
    • TB-500 (10 mg Vial) — Evidence profile
    • Tesamorelin (10 mg Vial) — Evidence profile
    • Testagen (20 mg Vial) — Evidence profile
    • Thymosin Alpha-1 (10 mg Vial) — Evidence profile
    • Tirzepatide (10 mg Vial) — Evidence profile
    • Tirzepatide (50 mg Vial) — Evidence profile
    • Vilon (20 mg Vial) — Evidence profile
  • Peptide Stacks
  • Peptide Blends
    • BPC157 + TB500 (20 mg Blend Vial) — Evidence profile
    • GLOW (70 mg Vial) — Evidence profile
    • KLOW (80 mg Vial) — Evidence profile
  • Calculator
  • Resources
close
08 Sep
Single Peptides

Tirzepatide (50 mg Vial) — Evidence profile

Tirzepatide has authorized manufactured products with specific indications and safety information. Clinical information should always name the product being discussed. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

SS-31 (50 mg Vial) — Evidence profile

Elamipretide has been studied in mitochondrial disease and is the ingredient in a US-authorized medicine for a specific Barth syndrome indication. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

SLU-PP-332 (10 mg Vial) — Evidence profile

SLU-PP-332 is a small-molecule research compound studied for estrogen-related receptor activity. The reviewed findings come from cells and animals. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

Semaglutide (30 mg Vial) — Evidence profile

Semaglutide is used in authorized medicines. A product’s indication, formulation and manufacturer instructions determine which evidence applies. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

Retatrutide (50 mg Vial) — Evidence profile

Retatrutide is being developed as an agonist of three metabolic hormone receptors. Published phase 2 and phase 3 findings provide clinical evidence, while approval and the identity of a retail product remain separate questions. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

Pinealon (10 mg Vial) — Evidence profile

Pinealon research explores how a short peptide affects cellular stress and nervous-system biology. The selected primary evidence is preclinical. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

MOTS-C (40 mg Vial) — Evidence profile

MOTS-c research connects mitochondrial signaling with metabolism and exercise. Published physiological observations and preclinical findings should be read separately from a registered human intervention trial whose results are not posted. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

LL-37 (10 mg Vial) — Evidence profile

Human LL-37 studies reviewed here evaluate local treatment of specific wounds. Their findings are mixed and should remain tied to those settings. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

Glutathione (1500 mg Vial) — Evidence profile

Glutathione participates in antioxidant biology. A biological role does not by itself establish benefit from a particular supplement or injectable product. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
08 Sep
Single Peptides

Epithalon (50 mg Vial) — Evidence profile

Epitalon research includes telomere biology and neuroendocrine experiments. These findings need careful separation from claims about human lifespan. This profile distinguishes the labelled product, study findings and evidence limits.

Read more

  • Facebook
  • X
  • Pinterest
  • LinkedIn
  • Telegram
123›»
Important Disclaimer: All information provided on PeptideDosing.ca is for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any new research protocol.

Your trusted source for comprehensive peptide dosage protocols and research information. Empowering researchers with accurate, science-based guidance.

Protocols
  • Single Peptides
  • Peptide Blends
  • Peptide Stacks
Learn
  • Beginner’s Guide
  • Reconstitution Guide
  • Syringe & Measurement Guide
  • Storage Guide
  • Glossary
  • FAQ
  • Calculator
  • Resources
Company
  • About Us
  • Editorial Policy
© 2026 PeptideDosing.ca — part of the Amino Labs group. All rights reserved.

Privacy Policy Terms & Conditions Cookie Policy Disclaimer

Scroll To Top
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
Accept